| Literature DB >> 25884791 |
Jihea Moon1, Giyoung Kim2, Saet Byeol Park3, Jongguk Lim4, Changyeun Mo5.
Abstract
Whole-cell Systemic Evolution of Ligands by Exponential enrichment (SELEX) is the process by which aptamers specific to target cells are developed. Aptamers selected by whole-cell SELEX have high affinity and specificity for bacterial surface molecules and live bacterial targets. To identify DNA aptamers specific to Staphylococcus aureus, we applied our rapid whole-cell SELEX method to a single-stranded ssDNA library. To improve the specificity and selectivity of the aptamers, we designed, selected, and developed two categories of aptamers that were selected by two kinds of whole-cell SELEX, by mixing and combining FACS analysis and a counter-SELEX process. Using this approach, we have developed a biosensor system that employs a high affinity aptamer for detection of target bacteria. FAM-labeled aptamer sequences with high binding to S. aureus, as determined by fluorescence spectroscopic analysis, were identified, and aptamer A14, selected by the basic whole-cell SELEX using a once-off FACS analysis, and which had a high binding affinity and specificity, was chosen. The binding assay was evaluated using FACS analysis. Our study demonstrated the development of a set of whole-cell SELEX derived aptamers specific to S. aureus; this approach can be used in the identification of other bacteria.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25884791 PMCID: PMC4431181 DOI: 10.3390/s150408884
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1(a) Schematic diagram of the basic whole-cell SELEX procedures used to isolate DNA aptamers with high binding affinity for Staphylococcus aureus; (b) Schematic diagram of the modified whole-cell SELEX process used to isolate DNA aptamers with a high binding affinity for Staphylococcus aureus.
Figure 2(a) Validation of the binding specificity of selected aptamer candidates by using the basic whole-cell SELEX procedure; (b) Validation of binding specificity of selected aptamer candidates by using the modified whole-cell SELEX procedure.
Sequences of selected aptamers for Staphylococcus aureus.
| Aptamers | Sequences |
|---|---|
| A2 | ACGGGCGTGGGAGGCAATGCCTTGCTTGTAGGCTTCCCCTGTGCGCG |
| A14 | CACACCGCAGCAGTGGGAACGTTTCAGCCATGCAAGCATCACGCCCGT |
| A15 | CACGCGCAAACAGATTAACACTCCGCCTAAGTCTGCCGCACGC |
| A20 | GCGTGCAGCGGGGGCTGCGCGGTGGAGTGCTGTGGGCG |
| B3 | GCGTGCGGAGCCAGGATGGGAGGTCTGTAGGTCTGCGGGGCGTG |
| B6 | GCGTGTCGGTGTCTGCCGGGGGATGTGGAGGCTGGGTGTTGCGCG |
| B7 | GCGTGGGCGGGCTACCTGGCTAGTACGCCATGATGCCTGCACGCG |
| B15 | CACGCGCAAACAGATTAACACTCCGCCTAAGTCTGCCGCACGC |
Figure 3Characterization of aptamers A14, B3, and B6 binding.
Figure 4Binding affinity analysis of aptamer A14.
Figure 5Predicted secondary structure of aptamer A14.